NEOPTERIN, BIOCHEMISTRY AND CLINICAL USE AS A MARKER FOR CELLULAR IMMUNE-REACTIONS

被引：205

作者：

FUCHS, D ^{[1
]}

WEISS, G ^{[1
]}

WACHTER, H ^{[1
]}

机构：

[1] LUDWIG BOLTZMANN INST AIDS RES, INNSBRUCK, AUSTRIA

来源：

INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY | 1993年 / 101卷 / 01期

关键词：

NEOPTERIN; CLINICAL USE; INTERFERON-GAMMA; ANEMIA; CACHEXIA;

D O I：

10.1159/000236491

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

Large amounts of neopterin are produced and released from human macrophages on stimulation with interferon-gamma. Neopterin is biologically stable, and it can be easily quantified in human body fluids. Neopterin measurements are useful to monitor allograft recipients to detect immunological complications. In autoimmune diseases, neopterin concentrations reflect the extent and activity of the disease. In infectious syndromes and in patients with cancer, neopterin concentrations provide prognostic information. In addition to providing clinically useful information, neopterin monitoring allows insight into the immunopathogenesis of a variety of diseases.

引用

页码：1 / 6

页数：6

共 54 条

[21]

FUCHS D, 1993, EUR J HAEMATOL, V50, P90

[22] THE ROLE OF NEOPTERIN AS A MONITOR OF CELLULAR IMMUNE ACTIVATION IN TRANSPLANTATION, INFLAMMATORY, INFECTIOUS, AND MALIGNANT DISEASES [J].

FUCHS, D ;

WEISS, G ;

REIBNEGGER, G ;

WACHTER, H .

CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 1992, 29 (3-4) :307-341

[23]

FUCHS D, 1989, CLIN CHEM, V35, P1746

[24]

FUCHS D, 1991, EUR J HAEMATOL, V46, P65

[25] DETERMINATION OF SERUM NEOPTERIN TO INCREASE THE SAFETY OF DONATED BLOOD FOR TRANSFUSION - RESULTS IN 76587 BLOOD-DONORS [J].

HONLINGER, M ;

FUCHS, D ;

HAUSEN, A ;

REIBNEGGER, G ;

SCHONITZER, D ;

WERNER, ER ;

REISSIGL, H ;

DIERICH, MP ;

WACHTER, H .

DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1989, 114 (05) :172-176

[26] IMMUNE-RESPONSE ASSOCIATED PRODUCTION OF NEOPTERIN - RELEASE FROM MACROPHAGES PRIMARILY UNDER CONTROL OF INTERFERON-GAMMA [J].

HUBER, C ;

BATCHELOR, JR ;

FUCHS, D ;

HAUSEN, A ;

LANG, A ;

NIEDERWIESER, D ;

REIBNEGGER, G ;

SWETLY, P ;

TROPPMAIR, J ;

WACHTER, H .

JOURNAL OF EXPERIMENTAL MEDICINE, 1984, 160 (01) :310-316

[27]

HUBER C, 1983, J IMMUNOL, V130, P1047

[28] SURROGATE MARKERS FOR SURVIVAL IN PATIENTS WITH AIDS AND AIDS RELATED COMPLEX TREATED WITH ZIDOVUDINE [J].

JACOBSON, MA ;

BACCHETTI, P ;

KOLOKATHIS, A ;

CHAISSON, RE ;

SZABO, S ;

POLSKY, B ;

VALAINIS, GT ;

MILDVAN, D ;

ABRAMS, D ;

WILBER, J ;

WINGER, E ;

SACKS, HS ;

HENDRICKSEN, C ;

MOSS, A .

BRITISH MEDICAL JOURNAL, 1991, 302 (6768) :73-78

[29]

KRAMER A, 1992, AM J EPIDEMIOL, V136, P71

[30]

KWON NS, 1989, J BIOL CHEM, V264, P20496

← 1 2 3 4 5 6 →